Biomarkers of early disease and progression in people with familial amyloid polyneuropathy

Takeaway

  • Early nerve degeneration in people with familial amyloid polyneuropathy (FAP) can be identified with skin biopsies.

Why this matters

  • Early diagnosis of people with FAP will ensure they receive treatment to slow disease progression before large-fiber nerves are affected.